# A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis

> **NCT03775434** · PHASE1 · COMPLETED · sponsor: **AOBiome LLC** · enrollment: 28 (actual)

## Conditions studied

- Eczema
- Atopic Dermatitis

## Interventions

- **DRUG:** Experimental: B244

## Key facts

- **NCT ID:** NCT03775434
- **Lead sponsor:** AOBiome LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-07
- **Primary completion:** 2019-05-18
- **Final completion:** 2019-06-10
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2024-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03775434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03775434, "A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03775434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*